Figures S1-S5 from Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

Fig. S1 (related to Fig. 1) shows in vitro effects of treatment. Fig. S2 (related to Fig. 2) shows live single-cell FastFUCCI analyses. Fig. S3 (related to Fig. 3) shows spatiotemporal effects of treatment. Fig. S4 (related to Fig. 4) shows CHK1/WEE1 expression analyses and in vitro effects of treatment. Fig. S5 (related to Fig. 5) shows in vivo effects of treatment.